Journal article
Multicenter real-world experience with epinephrine 0.5 mg dosing for anaphylaxis with allergen immunotherapy
Abstract
Aim: To determine the safety and efficacy of 0.5 mg intramuscular (IM) epinephrine for the treatment of subcutaneous allergen immunotherapy induced anaphylaxis. Patients & methods: Retrospective chart review of patients who received 0.5 mg of IM epinephrine for treatment of anaphylaxis from subcutaneous allergen immunotherapy at two outpatient allergy and immunology practices. Results: Thirty-eight patients received 0.5 mg IM epinephrine. …
Authors
Correa N; Quidwai A; Jeimy S; Rondilla N; White F; Moote W; Kuprowski M; Kim H
Journal
Immunotherapy, Vol. 13, No. 16, pp. 1325–1331
Publisher
Taylor & Francis
Publication Date
November 2021
DOI
10.2217/imt-2021-0142
ISSN
1750-743X